Global Cardiac Biomarkers Testing Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Myocardial Muscle Creatine Kinase (CK-MB)
  • 1.4.3 Troponins (T and I)
  • 1.4.4 Myoglobin
  • 1.4.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • 1.4.6 Ischemia-modified Albumin (IMA)
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Cardiac Biomarkers Testing Market Share by Application (2019-2025)
  • 1.5.2 Myocardial Infarction
  • 1.5.3 Congestive Heart Failure
  • 1.5.4 Acute Coronary Syndrome
  • 1.5.5 Atherosclerosis
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Cardiac Biomarkers Testing Market Size
• 2.2 Cardiac Biomarkers Testing Growth Trends by Regions
  • 2.2.1 Cardiac Biomarkers Testing Market Size by Regions (2019-2025)
  • 2.2.2 Cardiac Biomarkers Testing Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Cardiac Biomarkers Testing Market Size by by Players
  • 3.1.1 Global Cardiac Biomarkers Testing Revenue by by Players (2014-2019)
  • 3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)
• 3.2 Cardiac Biomarkers Testing Key Players Head office and Area Served
• 3.3 Key Players Cardiac Biomarkers Testing Product/Solution/Service
• 3.4 Date of Enter into Cardiac Biomarkers Testing Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Cardiac Biomarkers Testing Market Size by Type (2014-2019)
• 4.2 Global Cardiac Biomarkers Testing Market Size by Application (2014-2019)

5 North America

• 5.1 North America Cardiac Biomarkers Testing Market Size (2014-2019)
• 5.2 Cardiac Biomarkers Testing Key Players in North America
• 5.3 North America Cardiac Biomarkers Testing Market Size by Type
• 5.4 North America Cardiac Biomarkers Testing Market Size by Application

6 Europe

• 6.1 Europe Cardiac Biomarkers Testing Market Size (2014-2019)
• 6.2 Cardiac Biomarkers Testing Key Players in Europe
• 6.3 Europe Cardiac Biomarkers Testing Market Size by Type
• 6.4 Europe Cardiac Biomarkers Testing Market Size by Application

7 China

• 7.1 China Cardiac Biomarkers Testing Market Size (2014-2019)
• 7.2 Cardiac Biomarkers Testing Key Players in China
• 7.3 China Cardiac Biomarkers Testing Market Size by Type
• 7.4 China Cardiac Biomarkers Testing Market Size by Application

8 Japan

• 8.1 Japan Cardiac Biomarkers Testing Market Size (2014-2019)
• 8.2 Cardiac Biomarkers Testing Key Players in Japan
• 8.3 Japan Cardiac Biomarkers Testing Market Size by Type
• 8.4 Japan Cardiac Biomarkers Testing Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Cardiac Biomarkers Testing Market Size (2014-2019)
• 9.2 Cardiac Biomarkers Testing Key Players in Southeast Asia
• 9.3 Southeast Asia Cardiac Biomarkers Testing Market Size by Type
• 9.4 Southeast Asia Cardiac Biomarkers Testing Market Size by Application

10 India

• 10.1 India Cardiac Biomarkers Testing Market Size (2014-2019)
• 10.2 Cardiac Biomarkers Testing Key Players in India
• 10.3 India Cardiac Biomarkers Testing Market Size by Type
• 10.4 India Cardiac Biomarkers Testing Market Size by Application

11 Central & South America

• 11.1 Central & South America Cardiac Biomarkers Testing Market Size (2014-2019)
• 11.2 Cardiac Biomarkers Testing Key Players in Central & South America
• 11.3 Central & South America Cardiac Biomarkers Testing Market Size by Type
• 11.4 Central & South America Cardiac Biomarkers Testing Market Size by Application

12 International Players Profiles

• 12.1 Abbott Laboratories
  • 12.1.1 Abbott Laboratories Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Cardiac Biomarkers Testing Introduction
  • 12.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2014-2019))
  • 12.1.5 Abbott Laboratories Recent Development
• 12.2 Becton, Dickinson and Company
  • 12.2.1 Becton, Dickinson and Company Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Cardiac Biomarkers Testing Introduction
  • 12.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.2.5 Becton, Dickinson and Company Recent Development
• 12.3 BioMerieux
  • 12.3.1 BioMerieux Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Cardiac Biomarkers Testing Introduction
  • 12.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.3.5 BioMerieux Recent Development
• 12.4 Bio-Rad Laboratories, Inc.
  • 12.4.1 Bio-Rad Laboratories, Inc. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Cardiac Biomarkers Testing Introduction
  • 12.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.4.5 Bio-Rad Laboratories, Inc. Recent Development
• 12.5 Danaher Corporation
  • 12.5.1 Danaher Corporation Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Cardiac Biomarkers Testing Introduction
  • 12.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.5.5 Danaher Corporation Recent Development
• 12.6 F. HOFFMANN-LA ROCHE LTD.
  • 12.6.1 F. HOFFMANN-LA ROCHE LTD. Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Cardiac Biomarkers Testing Introduction
  • 12.6.4 F. HOFFMANN-LA ROCHE LTD. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.6.5 F. HOFFMANN-LA ROCHE LTD. Recent Development
• 12.7 Siemens AG
  • 12.7.1 Siemens AG Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Cardiac Biomarkers Testing Introduction
  • 12.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.7.5 Siemens AG Recent Development
• 12.8 Thermo Fisher Scientific, Inc.
  • 12.8.1 Thermo Fisher Scientific, Inc. Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Cardiac Biomarkers Testing Introduction
  • 12.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.8.5 Thermo Fisher Scientific, Inc. Recent Development
• 12.9 PerkinElmer Inc.
  • 12.9.1 PerkinElmer Inc. Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Cardiac Biomarkers Testing Introduction
  • 12.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.9.5 PerkinElmer Inc. Recent Development
• 12.10 Tosoh Corporation
  • 12.10.1 Tosoh Corporation Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Cardiac Biomarkers Testing Introduction
  • 12.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2014-2019)
  • 12.10.5 Tosoh Corporation Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer